Vanguard Is "Cautious" on U.S. Growth Stocks. These 2 Value ETFs Could Be Smarter Buys for Long-Term Investors.

Vanguard forecasts U.S. value stocks should outperform U.S. growth stocks over the next decade, with expected average annual returns of 6.4%–8.4% for value vs 3.6%–5.6% for growth as AI valuations are viewed as “already stretched.” The Vanguard Value Factor ETF (VFVA) has generated 12.4% annualized returns over the past five years (and 35.4% over the past year), while the small-cap value ETF (VBR) posted 9.75% annualized returns over five years (and 25.75% over the past year). The article argues that if AI-driven productivity gains broaden beyond mega-cap tech, smaller and more undervalued sectors could be better positioned.

Analysis

This is less a clean endorsement of “value” than a warning that the AI trade is transitioning from narrative-driven multiple expansion to a proof-of-earnings phase. The near-term winners are the cheaper sectors with operating leverage to broad productivity gains — banks, industrials, logistics, and selected cyclicals inside small-cap value — because any AI-driven efficiency shows up first in margins, not top-line growth. The second-order risk for mega-cap growth is not a collapse in fundamentals, but a steady multiple drain as capital rotates toward broader breadth and away from a handful of crowded duration assets.

The medium-term setup depends more on rates and credit than on style labels. Small-cap value only sustains outperformance if refinancing conditions stay benign and earnings revisions broaden; otherwise the basket becomes a collection of balance-sheet stories where “cheap” is just compensation for leverage and cyclicality. Within the named holdings, cash-rich compounders like EOG and INTU are better quality than telecoms or autos, while GM, T, and VZ look vulnerable to value-rotation hype because they need either cheaper funding or stronger demand than the market is likely to give them.

Contrarian take: consensus may be underestimating how long AI leaders can keep compounding despite rich valuations if monetization remains concentrated and capex stays rational. In that case, the best trade is not an unhedged value bet but a relative-value rotation with tight risk controls. Falsifiers are straightforward: a renewed decline in small-cap earnings revisions, widening HY spreads, or a sharp drop in long rates that re-energizes duration-sensitive growth multiples.

Key Decisions for Investors

• Long VBR / short QQQ for 3-6 months: best expression of a breadth rotation if AI leadership narrows. Risk/reward is attractive only if Nasdaq leadership stalls; cut if QQQ outperforms by ~5% or more on falling real yields.
• Long XLF or KRE versus short XLK on a 1-3 month horizon: banks and cyclicals should benefit if the market starts pricing AI as productivity support rather than just capex drag. Falsify if credit spreads widen or loan growth weakens.
• Within the value complex, long EOG versus short GM: EOG has cleaner cash conversion and less refinancing risk, while GM is more exposed to consumer credit and auto-cycle slippage.
• Avoid chasing BMY/PFE/VZ/T as a blanket value basket; treat them as potential value traps unless upcoming earnings/guidance show margin stabilization and lower funding sensitivity.
• Watchlist alert: add to small-cap value only after IWM/VBR show relative strength against QQQ plus stable high-yield spreads for several weeks; without that confirmation, this is likely a short-lived factor bounce.